2255-78-9

Basic information

• Product Name: 4-BROMO-7-BROMOMETHYL-BENZO[1,2,5]THIADIAZOLE
• Synonyms: 4-BROMO-7-BROMOMETHYL-BENZO[1,2,5]THIADIAZOLE
• CAS NO: 2255-78-9
• Molecular Formula: C₇H₄Br₂N₂S
• Molecular Weight: 307.99306
• Mol File: 2255-78-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-BROMO-7-BROMOMETHYL-BENZO[1,2,5]THIADIAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-7-BROMOMETHYL-BENZO[1,2,5]THIADIAZOLE(2255-78-9)
• EPA Substance Registry System: 4-BROMO-7-BROMOMETHYL-BENZO[1,2,5]THIADIAZOLE(2255-78-9)

Safety Data

• Hazardous Substances Data: 2255-78-9(Hazardous Substances Data)

Upstream product

• 601-87-6 3-methyl-2-nitroaniline 
• 2687-25-4 3-methyl-1,2-benzenediamine 
• 570-24-1 2-Methyl-6-nitroaniline 
• 2255-80-3 4-bromo-7-methylbenzo[c][1,2,5]thiadiazole 
• 1457-92-7 4-Methyl-2,1,3-benzothiadiazol 

Downstream Products

• 1331742-86-9 7-bromobenzo[c][1,2,5]thiadiazole-4-carbonitrile 
• 1372129-86-6 (E)-2-cyano-3-(7-(5-(N,N-bis(4-hexyloxyphenyl)-4-aminophenyl)-2,2'-bithien-5'-yl)benzo[c][1,2,5]thiadiazol-4-yl)acrylic acid 
• 1372129-89-9 7-(5-(N,N-bis(4-hexyloxyphenyl)-4-aminophenyl)-2,2'-bithien-5'-yl)benzo[c]-[1,2,5]thiadiazole-4-carbaldehyde 
• 1071224-34-4 7-bromobenzo[c][1,2,5]thiadiazole-4-carboxaldehyde 

Relevant articles and documents

COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN

The present disclosure provides a compound of Formula (I); or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.

Stepwise unidirectional synthesis of oligo phenylene vinylenes with a series of monomers. Use in plastic solar cells

Four new monomers for directional stepwise synthesis of oligophenylenevinylenes (OPVs) (4-{2-[4-(5,5-dimethyl[1,3]dioxan-2-yl)-2,5- dipropoxyphenyl]vinyl}benzyl)phosphonic acid diethyl ester, (5-{2-[4-(5,5- dimethyl[1,3]dioxan-2-yl)-2,5-dipropylphenyl]vinyl}thiophene-2-ylmethyl) phosphonic acid diethyl ester, (5-{2-[4-(5,5-dimethyl[1,3]dioxan-2-yl)-2,5- dipropoxyphenyl]vinyl}thiophene-2-ylmethyl)phosphonic acid diethyl ester, and (7-{2-[4-(5,5-dimethyl[1,3]dioxan-2-yl)-2,5-dipropylphenyl]-vinyl}benzo[1,2,5] thiadiazol-4-ylmethyl)phosphonic acid diethyl ester have been prepared. Trimeric OPVs were then synthesized and tested as active materials in photovoltaic cells. Conversion efficiencies in the range of 0.5-1% were obtained in blends with the soluble C60 derivative PCBM. A terpyridine end-functionalized trimer and a heterotrimer with a mixed composition of monomers were also prepared.